- Report
- May 2024
- 166 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- May 2024
- 174 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- May 2024
- 167 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- May 2024
- 169 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- April 2024
- 172 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- March 2024
- 175 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- March 2024
- 177 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- February 2024
- 170 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- February 2024
- 156 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2024
- 166 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2024
- 149 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2024
- 161 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2024
- 161 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2024
- 156 Pages
Asia Pacific
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2024
- 167 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2024
- 171 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2227EUR$2,500USD£1,932GBP
- Report
- December 2023
- 177 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- December 2023
- 155 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- November 2023
- 168 Pages
Global
From €2227EUR$2,500USD£1,932GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more